Sanofi U.S. strategy exec
Sanofi-Aventis names Juergen Lasowski, PhD, to head U.S. business development & strategy. He formerly served as Aventis VP-strategic planning & business and head of strategic development at predecessor company Hoechst Marion Roussel. Lasowski will report to Tim Rothwell, who became Sanofi-Aventis U.S. president following the completion of the merger (1"The Pink Sheet" June 28, 2004, p. 19)...
You may also be interested in...
Rhone-Poulenc Rorer Senior VP and General Manager John Leone is heading Aventis' North American Pharmaceuticals commercial operations - sales and marketing.
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.